U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Substance

Items: 1 to 20 of 616

1.
Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer
Heidi Godoy, Joshua P. Kesterson, Shashikant Lele
Int J Gynaecol Obstet. Author manuscript; available in PMC 2016 Oct 3.
Published in final edited form as: Int J Gynaecol Obstet. 2010 Jun; 109(3): 254. Published online 2010 Apr 1. doi: 10.1016/j.ijgo.2010.02.005
PMCID:
PMC5047375
ArticlePDF–34K
2.
Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
Keith T. Flaherty, Sandra J. Lee, Fengmin Zhao, Lynn M. Schuchter, Lawrence Flaherty, Richard Kefford, Michael B. Atkins, Philip Leming, John M. Kirkwood
J Clin Oncol. 2013 Jan 20; 31(3): 373–379. Published online 2012 Dec 17. doi: 10.1200/JCO.2012.42.1529
PMCID:
PMC4878104
AbstractArticlePDF–693K
3.
Feasibility of Intravenous Gemcitabine and an Intraperitoneal Platinum Agent in the Treatment of Ovarian Cancer
R.L. Giuntoli, II, R.E. Bristow, T.P. Diaz-Montes, D.K. Armstrong
J Chemother. Author manuscript; available in PMC 2016 May 18.
Published in final edited form as: J Chemother. 2011 Jun; 23(3): 163–167. doi: 10.1179/joc.2011.23.3.163
PMCID:
PMC4870588
AbstractArticlePDF–169K
4.
Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma
Shaum P. Bhagat, Johnnie K. Bass, Stephanie T. White, Ibrahim Qaddoumi, Matthew W. Wilson, Jianrong Wu, Carlos Rodriguez-Galindo
Int J Pediatr Otorhinolaryngol. Author manuscript; available in PMC 2016 Mar 11.
Published in final edited form as: Int J Pediatr Otorhinolaryngol. 2010 Oct; 74(10): 1156–1163. Published online 2010 Jul 29. doi: 10.1016/j.ijporl.2010.07.004
PMCID:
PMC4787621
AbstractArticlePDF–329K
5.
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Emma Kipps, David S. P. Tan, Stan B. Kaye
Nat Rev Cancer. Author manuscript; available in PMC 2015 Dec 9.
Published in final edited form as: Nat Rev Cancer. 2013 Apr; 13(4): 273–282. Published online 2013 Feb 21. doi: 10.1038/nrc3432
PMCID:
PMC4673904
AbstractArticlePDF–587K
6.
BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma
Kevin B. Kim, Jeffrey A. Sosman, John P. Fruehauf, Gerald P. Linette, Svetomir N. Markovic, David F. McDermott, Jeffrey S. Weber, Hoa Nguyen, Peter Cheverton, Daniel Chen, Amy C. Peterson, William E. Carson, III, Steven J. O'Day
J Clin Oncol. 2012 Jan 1; 30(1): 34–41. Published online 2011 Nov 28. doi: 10.1200/JCO.2011.34.6270
PMCID:
PMC4669379
AbstractArticlePDF–220K
7.
Molecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro
Jin-Shui Zhu, Bo Shen, Jin-Lian Chen, Guo-Qiang Chen, Xiao-Hu Yu, Hua-Fang Yu, Zu-Ming Zhu
World J Gastroenterol. 2003 Oct 15; 9(10): 2366–2369. Published online 2003 Oct 15. doi: 10.3748/wjg.v9.i10.2366
PMCID:
PMC4656500
AbstractArticlePDF–109K
8.
Analysis of the Cytotoxic Activity of the Carboplatin and Gemcitabine Combination
Sisi Wang, Hongyong Zhang, Liang Cheng, Christopher Evans, Chong-Xian Pan
Anticancer Res. Author manuscript; available in PMC 2015 Sep 8.
Published in final edited form as: Anticancer Res. 2010 Nov; 30(11): 4573–4578.
PMCID:
PMC4562399
AbstractArticlePDF–969K
9.
Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
Regina I. Jakacki, Peter C. Burger, Tianni Zhou, Emiko J. Holmes, Mehmet Kocak, Arzu Onar, Joel Goldwein, Minesh Mehta, Roger J. Packer, Nancy Tarbell, Charles Fitz, Gilbert Vezina, Joanne Hilden, Ian F. Pollack
J Clin Oncol. 2012 Jul 20; 30(21): 2648–2653. Published online 2012 Jun 4. doi: 10.1200/JCO.2011.40.2792
PMCID:
PMC4559602
AbstractArticlePDF–182K
10.
Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer
Nicholas W. Choong, Ann M. Mauer, Daniel J. Haraf, Eric Lester, Philip C. Hoffman, Mark Kozloff, Shang Lin, Janet E. Dancey, Livia Szeto, Tatyana Grushko, Olufunmilayo I. Olopade, Ravi Salgia, Everett E. Vokes
J Thorac Oncol. Author manuscript; available in PMC 2015 Aug 13.
Published in final edited form as: J Thorac Oncol. 2008 Sep; 3(9): 1003–1011. doi: 10.1097/JTO.0b013e31818396a4
PMCID:
PMC4535721
AbstractArticlePDF–1.3M
11.
Effects of Buthionine Sulfoximine Treatment on Cellular Glutathione Levels and Cytotoxicities of Cisplatin, Carboplatin and Radiation in Human Stomach and Ovarian Cancer Cell Lines: – Glutathione, Buthionine Sulfoximine, Cytotoxicity –
Kyung Shik Lee, Hoon-Kyo Kim, Hee Sook Moon, Young Seon Hong, Jin Hyung Kang, Dong Jip Kim, Jae-Gahb Park
Korean J Intern Med. 1992 Jul; 7(2): 111–117. doi: 10.3904/kjim.1992.7.2.111
PMCID:
PMC4532113
AbstractArticlePDF–398K
12.
A Less Intensive Combination of Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Patients who Have Aged 60 Years or More and Has a Poor Performance Status
Young Joo Min, Jong Joon Ahn, Young Ju Noh, Hee Jeong Cha, Jae Hee Suh, Jong Pil Jung, Chang Ryul Park, Ae Kyung Jeong, Jae Hoo Park, Ki Man Lee
Korean J Intern Med. 2004 Jun; 19(2): 109–113. doi: 10.3904/kjim.2004.19.2.109
PMCID:
PMC4531593
AbstractArticlePDF–393K
13.
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group Study
Natalie Gould, Michael W. Sill, Robert S. Mannel, Premal H. Thaker, Paul A. DiSilvestro, Steven E. Waggoner, S. Diane Yamada, Deborah K. Armstrong, Paula M. Fracasso, Joan L. Walker
Gynecol Oncol. Author manuscript; available in PMC 2015 Aug 6.
Published in final edited form as: Gynecol Oncol. 2012 Dec; 127(3): 506–510. Published online 2012 Aug 31. doi: 10.1016/j.ygyno.2012.08.037
PMCID:
PMC4527869
AbstractArticlePDF–278K
14.
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
Tao Chen, Mian Li, Ruiwen Zhang, Hui Wang
J Cell Mol Med. 2009 Jul; 13(7): 1358–1370. Published online 2008 May 3. doi: 10.1111/j.1582-4934.2008.00360.x
PMCID:
PMC4496149
AbstractArticlePDF–5.8M
15.
CONVECTION ENHANCED DELIVERY OF CARBOPLATIN IN COMBINATION WITH RADIOTHERAPY FOR THE TREATMENT OF BRAIN TUMORS
Weilian Yang, Tianyao Huo, Rolf F. Barth, Nilendu Gupta, Michael Weldon, John C. Grecula, Brian D. Ross, Benjamin A. Hoff, Ting-Chao Chou, Julia Rousseau, Hélène Elleaume
J Neurooncol. Author manuscript; available in PMC 2015 Jul 6.
Published in final edited form as: J Neurooncol. 2011 Feb; 101(3): 379–390. Published online 2010 Jun 25. doi: 10.1007/s11060-010-0272-z
Correction in:
volume 101 on page 391
PMCID:
PMC4492111
AbstractArticlePDF–497K
16.
Phase II Study Evaluating the Addition Of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Mohan Suntharalingam, Young Kwok, Olga Goloubeva, Arti Parekh, Rodney Taylor, Jeffrey Wolf, Ann Zimrin, Scott Strome, Robert Ord, Kevin J. Cullen
Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2015 May 28.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5): 1845–1850. Published online 2011 May 19. doi: 10.1016/j.ijrobp.2011.02.062
PMCID:
PMC4447113
AbstractArticlePDF–445K
17.
Outcomes of the POG 9340/9341/9342 Trials for Children with High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
Peter E. Zage, Morris Kletzel, Kevin Murray, Robert Marcus, Robert Castleberry, Yang Zhang, Wendy B. London, Cynthia Kretschmar
Pediatr Blood Cancer. Author manuscript; available in PMC 2015 May 9.
Published in final edited form as: Pediatr Blood Cancer. 2008 Dec; 51(6): 747–753. doi: 10.1002/pbc.21713
PMCID:
PMC4426094
AbstractArticlePDF–653K
18.
Impact of Prophylactic Conversion to an Extended Infusion Schedule to Prevent Hypersensitivity Reactions in Ovarian Cancer Patients during Carboplatin Retreatment
Roisin O’Cearbhaill, Qin Zhou, Alexia Iasonos, Martee L. Hensley, William P. Tew, Carol Aghajanian, David R. Spriggs, Stuart M. Lichtman, Paul J. Sabbatini
Gynecol Oncol. Author manuscript; available in PMC 2015 Mar 22.
Published in final edited form as: Gynecol Oncol. 2010 Mar; 116(3): 326–331. Published online 2009 Nov 27. doi: 10.1016/j.ygyno.2009.10.070
PMCID:
PMC4369374
AbstractArticlePDF–185K
19.
CARBOPLATIN-BASED PRIMARY CHEMOTHERAPY FOR INFANTS AND YOUNG CHILDREN WITH CNS TUMORS
Maryam Fouladi, Sri Gururangan, Albert Moghrabi, Peter Phillips, Lindsey Gronewold, Dana Wallace, Robert A. Sanford, Amar Gajjar, Larry E. Kun, Richard Heideman
Cancer. Author manuscript; available in PMC 2015 Jan 27.
Published in final edited form as: Cancer. 2009 Jul 15; 115(14): 3243–3253. doi: 10.1002/cncr.24362
PMCID:
PMC4307774
AbstractArticlePDF–396K
20.
Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer
Wolfgang Schuette, Maciej J. Krzakowski, Bartomeu Massuti, Gregory A. Otterson, Richard Lizambri, Helen Wei, Dietmar P. Berger, Yuhchyau Chen
J Thorac Oncol. Author manuscript; available in PMC 2015 Jan 6.
Published in final edited form as: J Thorac Oncol. 2012 Jan; 7(1): 157–164. doi: 10.1097/JTO.0b013e31822f6526
PMCID:
PMC4284819
AbstractArticlePDF–789K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center